EP. 1: Available Oncology Biosimilars and Their Efficacy
EP. 2: What Are Biosimilars?
EP. 3: Are Biosimilars and Biologics Similar?
EP. 4: Can Biosimilars Be Switched?
EP. 5: The FDA Approval of Biosimilars
EP. 6: The FDA Pathway for Interchangeable Biosimilars
EP. 7: Deciding Which Biosimilar to Use
EP. 8: How Biosimilars Have Impacted Cancer Treatment
EP. 9: Patient Access to Biosimilars
EP. 10: The Economic Impact of Biosimilars
EP. 11: The Role of Insurance Companies and PBMs on Biosimilar Access
EP. 12: Formulary Inclusion for Biosimilars
EP. 13: Biosimilar Challenges for Providers and Payers
EP. 14: Educating Patients and Clinicians About Biosimilars